Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
NCT03650205Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial in anthracycline-induced cardiotoxicity comparing Ivabradine with Placebo (2 arms). Primary endpoint: Ventricular function at 365 days. Status: unknown.
02
Drugs
ivabradine
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT03650205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03650205.